Fast detection and identification of microorganisms is a challenging and significant feature
from industry to medicine. Standard approaches are known to be very time-consuming and …

Fungal infections represent a constant and growing menace to public health. This concern is
due to the emergence of new fungal species and the increase in antifungal drug resistance …

As a novel risk factor, COVID-19 has led to an increase in the incidence of candidemia and
an elevated mortality rate. Despite being of clinical importance, there is a lack of data …

Clonal outbreaks of fluconazole-resistant (FLZR) Candida parapsilosis isolates have been
reported in several countries. Despite its being the second leading cause of candidemia, the …

As the second leading etiological agent of candidemia in Turkey and the cause of severe
fluconazole-non-susceptible (FNS) clonal outbreaks, Candida parapsilosis emerged as a …

Background Despite being associated with a high mortality and economic burden, data
regarding candidemia are scant in Algeria. The aim of this study was to unveil the …

Our understanding of fungal epidemiology and the burden of antifungal drug resistance in
COVID-19-associated candidemia (CAC) patients is limited. Therefore, we conducted a …

Extensive advances in technology offer a vast variety of diagnostic methods that save time
and costs, but identification of fungal species causing human infections remains challenging …

Recurrent vulvovaginal candidiasis (RVVC) is one of the most prevalent fungal infections in
humans, especially in develo** countries; however, it is underestimated and regarded as …

Background Echinocandin resistance rarely occurs in clinical Candida parapsilosis isolates
and the underlying mechanism is unknown. Objectives To determine the prevalence of …